1,25-Dihydroxyvitamin D inhibits hepatic diacyglycerol accumulation and ameliorates metabolic dysfunction in polycystic ovary syndrome rat models
Introduction: We aimed to evaluate the influence of 1,25-dihydroxyvitamin D (1,25(OH)2D) on metabolic dysfunction and elucidate its underlying mechanism using a rat model of polycystic ovary syndrome (PCOS).Methods: Twenty-four Sprague-Dawley rats were randomly divided into four groups: control grou...
Main Authors: | Xin Yuan, Jianshu Yang, Danlin Sun, Kaiming Luo, Xiaohong Jiang, Long Wang, Shoukui Xiang, Yijie Jiang, Kele Ge, Zhiyang Zhou, Bowen Li, Fei Hua |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1077014/full |
Similar Items
-
Differential Lipidomic Characteristics of Children Born to Women with Polycystic Ovary Syndrome
by: Zhirong Zhang, et al.
Published: (2021-08-01) -
Lipidomics analysis of human follicular fluid form normal-weight patients with polycystic ovary syndrome: a pilot study
by: Yanna Ban, et al.
Published: (2021-10-01) -
Polycystic Ovary Syndrome in Adolescence
by: Rebecca Deans
Published: (2019-10-01) -
Berberine in the treatment of polycystic ovary syndrome
by: Łukasz Ochyra, et al.
Published: (2022-04-01) -
Estrogen Receptors in Polycystic Ovary Syndrome
by: Xue-Ling Xu, et al.
Published: (2021-02-01)